Impact of single use negative pressure wound therapy on surgical incisions following breast surgery: a multi-centre evaluation
Association of Breast Surgery ePoster Library. Whittall C. 05/13/19; 257168; P126
Dr. Catherine Whittall
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
P126
Topic: Other
Introduction: The aim of this evaluation was to determine the impact of single-use negative pressure wound therapy (sNPWT) dressings when used prophylactically on patients considered high-risk for wound healing, undergoing therapeutic breast surgery. A service evaluation was initiated with hospitals currently using sNPWT within their breast surgery unit with an aim of determining the impact of sNPWT within a real world setting. Method: Data were collected between December 2016 and August 2018 from three hospitals. A baseline sample of 66 patients were documented at discharge and follow up to ascertain the current base rate of complications following breast surgery within the hospitals. The outcomes of a further 66 patients, treated with sNPWT, were documented in identical fashion and comparisons were made between the cohorts. Results: The use of sNPWT reduced the number of deep surgical site infections (SSIs) from three in the non-sNPWT group to zero in the sNPWT group. Similarly, superficial SSIs were reduced from 9/66 to 2/66. Overall, the use of sNPWT reduced SSI incidence by 75%. The combined data shows an estimated total cost reduction from £22,896 to £13,479, an estimated saving of £9,417. Conclusion: The results of this evaluation complement the current evidence for sNPWT following breast surgery, and highlights the potential impact when implemented into clinical practice, by use of a pre-determined pathway for application on high-risk patients. It also demonstrates the reduction in wound complications as a direct result of prophylactic sNPWT and the potential for cost-savings to a hospital.
Topic: Other
Introduction: The aim of this evaluation was to determine the impact of single-use negative pressure wound therapy (sNPWT) dressings when used prophylactically on patients considered high-risk for wound healing, undergoing therapeutic breast surgery. A service evaluation was initiated with hospitals currently using sNPWT within their breast surgery unit with an aim of determining the impact of sNPWT within a real world setting. Method: Data were collected between December 2016 and August 2018 from three hospitals. A baseline sample of 66 patients were documented at discharge and follow up to ascertain the current base rate of complications following breast surgery within the hospitals. The outcomes of a further 66 patients, treated with sNPWT, were documented in identical fashion and comparisons were made between the cohorts. Results: The use of sNPWT reduced the number of deep surgical site infections (SSIs) from three in the non-sNPWT group to zero in the sNPWT group. Similarly, superficial SSIs were reduced from 9/66 to 2/66. Overall, the use of sNPWT reduced SSI incidence by 75%. The combined data shows an estimated total cost reduction from £22,896 to £13,479, an estimated saving of £9,417. Conclusion: The results of this evaluation complement the current evidence for sNPWT following breast surgery, and highlights the potential impact when implemented into clinical practice, by use of a pre-determined pathway for application on high-risk patients. It also demonstrates the reduction in wound complications as a direct result of prophylactic sNPWT and the potential for cost-savings to a hospital.
P126
Topic: Other
Introduction: The aim of this evaluation was to determine the impact of single-use negative pressure wound therapy (sNPWT) dressings when used prophylactically on patients considered high-risk for wound healing, undergoing therapeutic breast surgery. A service evaluation was initiated with hospitals currently using sNPWT within their breast surgery unit with an aim of determining the impact of sNPWT within a real world setting. Method: Data were collected between December 2016 and August 2018 from three hospitals. A baseline sample of 66 patients were documented at discharge and follow up to ascertain the current base rate of complications following breast surgery within the hospitals. The outcomes of a further 66 patients, treated with sNPWT, were documented in identical fashion and comparisons were made between the cohorts. Results: The use of sNPWT reduced the number of deep surgical site infections (SSIs) from three in the non-sNPWT group to zero in the sNPWT group. Similarly, superficial SSIs were reduced from 9/66 to 2/66. Overall, the use of sNPWT reduced SSI incidence by 75%. The combined data shows an estimated total cost reduction from £22,896 to £13,479, an estimated saving of £9,417. Conclusion: The results of this evaluation complement the current evidence for sNPWT following breast surgery, and highlights the potential impact when implemented into clinical practice, by use of a pre-determined pathway for application on high-risk patients. It also demonstrates the reduction in wound complications as a direct result of prophylactic sNPWT and the potential for cost-savings to a hospital.
Topic: Other
Introduction: The aim of this evaluation was to determine the impact of single-use negative pressure wound therapy (sNPWT) dressings when used prophylactically on patients considered high-risk for wound healing, undergoing therapeutic breast surgery. A service evaluation was initiated with hospitals currently using sNPWT within their breast surgery unit with an aim of determining the impact of sNPWT within a real world setting. Method: Data were collected between December 2016 and August 2018 from three hospitals. A baseline sample of 66 patients were documented at discharge and follow up to ascertain the current base rate of complications following breast surgery within the hospitals. The outcomes of a further 66 patients, treated with sNPWT, were documented in identical fashion and comparisons were made between the cohorts. Results: The use of sNPWT reduced the number of deep surgical site infections (SSIs) from three in the non-sNPWT group to zero in the sNPWT group. Similarly, superficial SSIs were reduced from 9/66 to 2/66. Overall, the use of sNPWT reduced SSI incidence by 75%. The combined data shows an estimated total cost reduction from £22,896 to £13,479, an estimated saving of £9,417. Conclusion: The results of this evaluation complement the current evidence for sNPWT following breast surgery, and highlights the potential impact when implemented into clinical practice, by use of a pre-determined pathway for application on high-risk patients. It also demonstrates the reduction in wound complications as a direct result of prophylactic sNPWT and the potential for cost-savings to a hospital.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}